Medical progress - Ductal carcinoma in situ of the breast

被引：396

作者：

Burstein, HJ

Polyak, K

Wong, JS

Lester, SC

Kaelin, CM

机构：

[1] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA

[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Surg, Boston, MA 02115 USA

[5] Harvard Univ, Sch Med, Boston, MA USA

[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 14期

关键词：

D O I：

10.1056/NEJMra031301

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1430 / 1441

页数：12

共 127 条

[31]

Ernster VL, 2002, JNCI-J NATL CANCER I, V94, P1546

[32] Incidence of and treatment for ductal carcinoma in situ of the breast [J].

Ernster, VL ;

Barclay, J ;

Kerlikowske, K ;

Grady, D ;

Henderson, IC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12) :913-918

[33]

EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223

[34] Genetic pathways in the evolution of breast ductal carcinoma in situ [J].

Farabegoli, F ;

Champeme, MH ;

Bieche, I ;

Santini, D ;

Ceccarelli, C ;

Derenzini, M ;

Lidereau, R .

JOURNAL OF PATHOLOGY, 2002, 196 (03) :280-286

[35]

FAVERLY DRG, 1994, SEMIN DIAGN PATHOL, V11, P193

[36] Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial [J].

Fisher, B ;

Dignam, J ;

Wolmark, N ;

Wickerham, DL ;

Fisher, ER ;

Mamounas, E ;

Smith, R ;

Begovic, M ;

Dimitrov, NV ;

Margolese, RG ;

Kardinal, CG ;

Kavanah, MT ;

Fehrenbacher, L ;

Oishi, RH .

LANCET, 1999, 353 (9169) :1993-2000

[37] Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience [J].

Fisher, B ;

Land, S ;

Mamounas, E ;

Dignam, J ;

Fisher, ER ;

Wolmark, N .

SEMINARS IN ONCOLOGY, 2001, 28 (04) :400-418

[38] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[39] Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less [J].

Fisher, B ;

Bryant, J ;

Dignam, JJ ;

Wickerham, DL ;

Mamounas, EP ;

Fisher, ER ;

Margolese, RG ;

Nesbitt, L ;

Paik, S ;

Pisansky, TM ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4141-4149

[40] LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

FISHER, E ;

MARGOLESE, R ;

DIMITROV, N ;

WOLMARK, N ;

WICKERHAM, DL ;

DEUTSCH, M ;

ORE, L ;

MAMOUNAS, E ;

POLLER, W ;

KAVANAH, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1581-1586

← 1 2 3 4 5 6 7 8 9 10 →